|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.950 USD | +2.09% |
|
-72.18% | -73.51% |
| 07-31 | Top Midday Decliners | MT |
| 07-31 | Baird Downgrades Karyopharm Therapeutics to Neutral From Outperform, Adjusts Price Target to $3 From $15 | MT |
| Market Cap | 44.19M 38.35M 35.91M 32.85M 62.01M 4.21B 62.82M 420M 165M 2.1B 166M 162M 7B | P/E 2026 * |
-0.45x | P/E 2027 * | -0.72x |
|---|---|---|---|---|---|
| Enterprise Value | 44.19M 38.35M 35.91M 32.85M 62.01M 4.21B 62.82M 420M 165M 2.1B 166M 162M 7B | EV / Sales 2026 * |
0.33x | EV / Sales 2027 * | 0.25x |
| Free-Float |
95.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Karyopharm Therapeutics Inc.
| 1 day | +2.09% | ||
| 1 week | -72.18% | ||
| Current month | +1.56% | ||
| 1 month | -79.73% | ||
| 3 months | -78.38% | ||
| 6 months | -68.85% | ||
| Current year | -73.51% |
| 1 week | 1.8 |  | 2.11 |
| 1 month | 1.8 | | 10.86 |
| Current year | 1.8 | | 10.99 |
| 1 year | 1.8 | | 10.99 |
| 3 years | 1.8 | | 29.25 |
| 5 years | 1.8 | | 220.95 |
| 10 years | 1.8 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 02/05/2021 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 02/01/2025 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 62 | 31/12/2012 |
| Director/Board Member | 61 | 31/03/2013 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 02/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/07/26 | Sell | Executive/Senior Manager | -189 | 0.0008% | ||
| 14/05/26 | Sell | Controller/Auditor | -53 | 0.0002% | ||
| 17/02/26 | Sell | Executive/Senior Manager | 378 | 0.0021% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.09% | -72.18% | -51.61% | -92.44% | 44.19M | |
| +0.46% | +4.57% | +39.09% | +0.74% | 77.1B | |
| +1.07% | +2.11% | +23.36% | +184.78% | 49.43B | |
| +1.54% | -0.85% | -4.49% | +23.71% | 49.27B | |
| -0.13% | +7.42% | -50.22% | -49.58% | 44.59B | |
| -0.17% | -0.79% | +59.49% | -23.29% | 30.48B | |
| -1.19% | -3.75% | +52.45% | +86.04% | 24B | |
| -4.26% | -7.01% | +101.65% | -50.22% | 21.5B | |
| +4.29% | +9.40% | +3.77% | +226.51% | 20.18B | |
| +1.26% | -3.95% | +64.96% | +123.32% | 16.29B | |
| Average | +0.51% | -7.25% | +23.85% | +42.96% | 33.29B | |
| Weighted average by Cap. | +0.43% | +1.47% | +24.32% | +45.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 134M 116M 109M 99.41M 188M 12.74B 190M 1.27B 499M 6.37B 502M 491M 21.19B | 175M 152M 142M 130M 245M 16.63B 248M 1.66B 651M 8.31B 656M 641M 27.66B |
| Net income | -118M -102M -95.91M -87.73M -166M -11.24B -168M -1.12B -440M -5.62B -443M -434M -18.7B | -105M -91.04M -85.24M -77.98M -147M -9.99B -149M -997M -391M -4.99B -394M -385M -16.62B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | US$1.950 | +2.09% | 1,189,123 |
| 05/08/26 | US$1.910 | -2.55% | 2,376,615 |
| 04/08/26 | US$1.960 | -0.51% | 3,792,123 |
| 03/08/26 | US$1.970 | +2.60% | 4,514,606 |
| 31/07/26 | US$1.920 | -72.61% | 22,398,319 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KPTI Stock
Select your edition
All financial news and data tailored to specific country editions
